This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Aventis Pharma Deutschland, Gmbh. Active years: 2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005
Title: Andrea Brüggemann: Innovator in Cation Channel Modulation
Introduction
Andrea Brüggemann is a notable inventor based in Frankfurt am Main, Germany. She has made significant contributions to the field of pharmacology, particularly in the modulation of hyperpolarization-activated cation channels. Her work is essential for advancing our understanding of various physiological processes and potential therapeutic applications.
Latest Patents
Andrea holds a patent for a "Process for identifying substances which modulate the activity of hyperpolarization-activated cation channels." This invention provides a method for identifying substances that can influence the activity of these channels, which play a crucial role in cellular excitability and signaling.
Career Highlights
Andrea is currently employed at Aventis Pharma Deutschland GmbH, where she applies her expertise in pharmacology and innovation. Her work at the company has allowed her to contribute to the development of new therapeutic strategies.
Collaborations
Throughout her career, Andrea has collaborated with esteemed colleagues, including Hans-Willi Jansen and Holger Heitsch. These collaborations have enriched her research and expanded the impact of her inventions.
Conclusion
Andrea Brüggemann is a pioneering inventor whose work in cation channel modulation is paving the way for new therapeutic approaches. Her contributions to science and medicine are invaluable and continue to inspire future innovations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile